Redox changes in aged placental bed: consequences for cell signalling by Silveira, Sandra Isabel Cunha
Sandra Isabel Cunha Silveira
outubro de 2013
Redox changes in aged placental bed: 
consequences for cell signalling
U
M
in
h
o
|
2
0
1
3
S
a
n
d
ra
 I
s
a
b
e
l 
C
u
n
h
a
 S
il
ve
ir
a
R
e
d
o
x
 c
h
a
n
g
e
s
 i
n
 a
g
e
d
 p
la
c
e
n
ta
l 
b
e
d
: 
c
o
n
s
e
q
u
e
n
c
e
s
 f
o
r
 c
e
ll
 s
ig
n
a
ll
in
g
Universidade do Minho
Escola de Ciências
Sandra Isabel Cunha Silveira
outubro de 2013
Dissertação de Mestrado 
Mestrado em Genética Molecular
Redox changes in aged placental bed: 
consequences for cell signalling
Universidade do Minho
Escola de Ciências
Trabalho realizado sob a orientação da
Doutora Elisabete Silva
e do
Professor Doutor Henrique Almeida
e da
Professora Doutora Cristina Pereira-Wilson

 III 
 
Acknowledgements 
 
 
Em primeiro lugar, gostaria de agradecer à minha orientadora, Doutora Elisabete 
Silva, por me integrar no seu próprio projecto de investigação, acompanhar as suas 
experiências e participar na sua execução, pela sua orientação, aconselhamento, apoio e 
paciência. 
 
Gostaria ainda de agradecer ao Professor Henrique Almeida por me aceitar no 
grupo Ageing and Stress e assumir a co-orientação. 
 
Gostaria de agradecer à Sra. Professora Deolinda Lima, directora do 
Departamento de Biologia Experimental da Faculdade de Medicina da Universidade do 
Porto, onde o trabalho se realizou, e por extensão, a todos os quantos que aí exercem, 
em especial os meus colegas de laboratório, Ana Isabel Soares e Anabela Silvestre, 
pelas ajudas ao longo do ano. 
 
Um agradecimento especial ao Dr. Luis Guedes-Martins do Centro Hospitalar do 
Porto, Unidade Maternidade Júlio Dinis, por nos facultar os tecidos que permitiram a 
realização desta dissertação de mestrado. 
 
Gostaria, igualmente, de agradecer aos meus pais e irmã pelo apoio. 
 
Por fim, gostaria de agradecer a Brian Baron por todo o apoio, ajuda, por 
acreditar em mim e por estar sempre presente quando preciso. 
  
Redox changes in aged placental bed: consequences for cell signalling 
V 
 
Abstract 
 
The occurrence of pregnancy-related disorders such as preeclampsia, IUGR or 
foetal death is associated with increased maternal age. These pregnancy complications 
are thought to be a consequence of a local imbalance in redox homeostasis, leading to 
an abnormal placentation, placental development and function. In placental bed, the 
uterine place where placenta adheres, ROS can react with biomolecules and alter cell 
function, though modification of cell signalling pathways involved in placentation or 
induction of cellular damage. 
In this project it was hypothesized that at older reproductive age loss of redox 
homeostasis at the placental bed contributes to disruption of foetal/placental interactions 
and enhances the development of pregnancy complications. Therefore, to address this 
hypothesis, evaluation of oxidative stress markers and activation of cell signalling 
pathways was performed in samples of uterine placental bed of women at different ages. 
Employing a human cell stress-related protein expression array kit, it was observed that 
in reproductively older women the protein expression of cytochrome c, FABP-1 and 
ADAMTS1 were significantly increased. The array was validated by western blot, using 
antibodies for SODII, HSP70, Sirt2 and phospho-p38α. Western blot, also demonstrated 
a significant age-related increase SODII expression. Results show a local redox 
imbalance in placental bed of reproductively older women that could lead to increased 
cellular oxidative stress (OS). As marker of cellular OS, a protein carbonylation assay 
was used. Although no significant changes were observed in total protein carbonylation 
content, quantification of specific carbonylated proteins showed a positive correlation 
with maternal age. As mild increases in OS can alter signalling pathways, an additional 
human phospho-kinase array kit was employed to study the same tissue. STAT3 protein 
phosphorylation had over 100% increase in expression. OS status was also evaluated in 
pregnancy-related disorders. SODI, SODII and Sirt2 protein expression was evaluated 
by western blot. SODI and Sirt2 expression was increased in pregnancies of 
hypertensive women with or without pre-eclampsia. SODII expression had no 
significant changes in all groups. Once again, only a specific protein was significantly 
increased in the group of women with gestational hypertension and IUGR of the foetus. 
This project gathered information on local uterine redox status and cell signal in 
reproductively older women and demonstrated that alterations in tissue redox balance 
are present in a maternal tissue, even in pregnancies without associated complications
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Resumo 
 
A ocorrência de complicações relacionadas com a gravidez como a pré-
eclâmpsia, restrição ao crescimento intra-uterino ou morte fetal, está associada com o 
aumento da idade materna. Elas podem ser consequência de um desequilíbrio local no 
balanço redox, que estará na origem de uma placentação anormal. No local de 
placentação, o local uterino onde a placenta adere, as espécies reactivas de oxigénio 
podem reagir com biomoléculas e alterar funções celulares, quer por modificação de 
vias de sinalização, quer por indução de danos celulares. 
Neste projeto, colocou-se a hipótese de em idade reprodutiva avançada ocorrer 
um desequilíbrio do balanço redox no local de placentação, que contribui para a 
instabilidade da interacção feto/placenta e o aumento da probabilidade de ocorrerem 
complicações. Para testar esta hipótese foram avaliados marcadores de stress oxidativo e 
indicadores de activação de vias de sinalização celular em amostras de local de 
placentação de mulheres com diferentes idades. Recorrendo a um array de expressão de 
proteínas relacionadas com o stress celular, observou-se que em mulheres com idade 
reprodutiva avançada a expressão do citocromo c, FABP-1 e ADAMTS1 estava 
aumentada significativamente. A validação do array foi realizada por Western blotting 
utilizando anticorpos para SODII, HSP70, Sirtuin2 e fosfo-p38α. Os resultados do 
Western blot demonstraram aumento significativo da expressão da SOD II com a idade 
materna. Nesta primeira parte do trabalho, observou-se um desequilíbrio redox no local 
de placentação em mulheres com idade reprodutiva avançada, que poderá originar um 
aumento do stress oxidativo. Quando se empregou a carbonilação de proteínas como 
marcador de stress oxidativo, não se observaram alterações significativas no conteúdo 
total de carbonilos, mas a quantificação de proteínas específicas mostrou uma 
correlação positiva entre a carbonilação e a idade materna. Além disso, atendendo a que 
um ligeiro aumento do stress oxidativo pode alterar vias de sinalização, empregou-se 
um array de cínases de fosfatases para o seu estudo. A proteína STAT3 fosforilada teve 
um aumento da expressão superior a 100%. 
Na segunda parte do trabalho, em gravidezes com complicações associadas, a 
expressão proteica das enzimas antioxidantes SODI, SODII e da Sirtuin2, avaliadas por 
Western Blotting, mostrou que em mulheres hipertensas com ou sem pré-eclampsia, a 
SODI e Sirt2 estavam aumentadas, enquanto a expressão da SODII não apresentou 
alterações significativas. O estudo da carbonilação proteica demonstrou que apenas uma 
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proteína específica se encontra significativamente aumentada no grupo de mulheres com 
hipertensão gestacional e restrição ao crescimento intra-uterino. 
Este projecto reuniu informação sobre o estado redox e sinalização celular no 
local de placentação em mulheres com idade reprodutiva avançada e demonstrou a 
existência de alterações no equilíbrio redox uterino, mesmo em gravidezes sem 
complicações associadas. 
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1. Introduction  
 
Nowadays, in modern societies, women are postponing childbearing beyond the 
age of 35 years old (Balasch and Gratacós 2011). Higher education, pursuit of a career, 
economic independence, effective contraception, longer life expectation and the 
promise of advanced reproductive technologies are reasons for the decision of having 
their first child in later age (van Katwijk and Peeters 1998, Istance and Theisens 2008). 
As women’s fertility declines with age, being more notorious after 35 years-old, it leads 
to an increased risk of developing pregnancy-related complications like hypertension, 
pre-eclampsia and intrauterine growth restriction (IUGR), that can affect both mother 
and foetus during pregnancy and labour (van Katwijk and Peeters 1998). 
Various observations favour the view that some pregnancy-related complications 
are due to an abnormal placental bed, the uterine environment where the placenta 
adheres, which in turn may result, from altered redox status, consequence to an 
imbalance between the activity of pro-oxidant and anti-oxidant molecules. This 
promotes reactive oxygen species (ROS) effects and the establishment of oxidative 
stress (OS). This condition can induce alterations in signalling pathways and damage to 
biomolecules such as proteins, DNA and lipids (Myatt and Cui 2004). 
 
1.1. Placentation and placental bed 
 
Placentation is the process of formation and development of the placenta and the 
associated anatomical modifications in maternal tissue. In humans, it involves the 
development of three regions (Figure 1). 
The first region is called foetal placenta and contains both foetal and maternal 
blood and is the place where physiological exchange of nutrients and waste products 
occurs (Georgiades, Ferguson-Smith et al. 2002). The second region is termed basal 
plate and is a region that borders the maternal surface next to the foetal placenta 
although it does not contain any foetal blood and is transversed by maternal vessels. 
This region can also be called implantation site. The third region is known as placental 
bed and is constituted by maternal uterine tissue that contains the decidua basalis, which 
is the term given to the uterine endometrium specially modified to enable implantation. 
Introduction 
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Figure 1. Human Placentation. Placentation involves the development of three regions: foetal placenta, 
which protects the foetus and serve as a gas and hormone exchange; basal plate which borders the 
maternal surface and the foetal placenta; and placental bed where trophoblast invasion and the 
physiological change occurs. Extracted from Georgiades, Ferguson-Smith et al. 2002 
 
Placental bed contains 100-150 maternal spiral arteries (Georgiades, Ferguson-
Smith et al. 2002, Lyall 2002). Maternal spiral arteries supply nutrients and oxygen to 
the placenta (Lyall 2005). But, for the success of a healthy pregnancy it is necessary that 
maternal spiral arteries are transformed into flaccid vessels in a physiological process 
where endovascular invasion of the arterial lumen by trophoblasts is a crucial process 
(Redline 2008). Trophoblast invasion through the uterine stroma is also fundamental for 
anchoring the placenta into the uterine wall. There is no doubt that placental bed plays a 
role is supporting placenta function and that failure in the setting up of the physiological 
changes may lead to pre-eclampsia, foetal growth restriction or even spontaneous 
miscarriage (Lyall 2005). 
An imbalance in placental bed redox status is thought to contribute to the 
development of the above-mentioned pregnancy complications (Myatt and Cui 2004). 
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1.2. Oxidative stress 
 
OS is described as an imbalance between the production of ROS/reactive 
nitrogen species (RNS) and the levels of antioxidant molecules, able to scavenge them 
(Myatt and Cui 2004). It is the basis of one of the most widely accepted theories of 
ageing (Harman 1956). 
Pregnancy is known as a state of OS arising from an increased metabolic activity 
of mitochondria and increased ROS and RNS production in the placenta and the 
reduction of antioxidant defence mechanisms (Myatt and Cui 2004, Agarwal, Aponte-
Mellado et al. 2012). A balance between ROS and RNS production and antioxidant 
defence is necessary to maintain cellular homeostasis (Lázár 2012), since ROS and RNS 
are needed for a correct cell function (Agarwal, Aponte-Mellado et al. 2012). However, 
when the production of pro-oxidant molecules increases or when the antioxidant 
defences decrease (Gupta, Malhotra et al. 2009) this originates an imbalance in the 
redox equilibrium and leads to a disturbance in cellular metabolism and regulatory  
pathways (Lázár 2012). 
ROS play an important signalling role in female fertility and pregnancy. Indeed 
they are needed for physiological processes involved in oocyte maturation, fertilization, 
implantation and embryo development (Burton and Jauniaux 2011). ROS can alter 
trophoblasts proliferation and differentiation and placental vascular reactivity, thus 
being important regulators of placental function (Myatt and Cui 2004, Webster, Roberts 
et al. 2008). As such, an imbalance in cellular levels of ROS, leading to OS, may be 
implied in placental dysfunction and the development of pregnancy complications. 
Most ROS are free radicals containing one or more unpaired electrons but some 
ROS are not free radicals. Nevertheless, both have high reactivity (Burton and Jauniaux 
2011) and can induce cellular damage (Myatt and Cui 2004). One of the most reactive 
ROS is superoxide anion (O2
-) (Myatt and Cui 2004, Gupta, Malhotra et al. 2009, 
Agarwal, Aponte-Mellado et al. 2012, Lázár 2012). The major source of O2
- is the 
mitochondria, through the mitochondrial respiratory chain (Agarwal, Aponte-Mellado et 
al. 2012) but other sources of O2
- include the short electron chain in the endoplasmic 
reticulum, xanthine oxidase, nitric oxide synthase (Myatt and Cui 2004), cytochrome 
P450 and the enzyme adenine dinucleotide phosphate (NADPH) oxidase (Figure 2). 
NADPH oxidase produces substantial quantities of O2
- during early pregnancy 
(Burton and Jauniaux 2011) that it is believed to be implicated  in cell signalling events, 
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which leads to up-regulation of transcription factors, antioxidant production, 
angiogenesis, proliferation and matrix remodelling (Myatt and Cui 2004, Webster, 
Roberts et al. 2008, Gupta, Malhotra et al. 2009). O2
- can be neutralized enzymatically 
by superoxide dismutase (SOD) and converted into hydrogen peroxide (H2O2), which, 
although less reactive is more stable and membrane permeable. In the cells H2O2 can be 
convert into water by catalase and glutathione peroxidase (Burton and Jauniaux 2011). 
SOD has three isoforms: copper/zinc SOD (Cu/Zn SOD) or SODI that is located in the 
cytosol, Manganese SOD (Mn SOD) or SODII, located in the mitochondria and SODIII, 
an extracellular isoform that is structurally similar to Cu/Zn SOD. SODI and SODII 
isoforms have cell specific distribution in the placenta. SODI is intensely expressed in 
villous stroma whereas SODII is expressed strongly in the villous endothelium and 
faintly expressed in syncytiotrophoblast (Myatt and Cui 2004). 
ROS can be neutralized by antioxidants. Antioxidants are molecules that protect 
the cell against ROS by dramatically delaying or preventing oxidation. They can be 
enzymatic or non-enzymatic: SOD, thioredoxin, thioredoxin reductase, catalase, 
glutathione peroxidase are endogenous enzymatic antioxidants (Agarwal, Aponte-
Mellado et al. 2012), while vitamins C and E and glutathione are non-enzymatic 
antioxidants (Gupta, Malhotra et al. 2009). 
 
Figure 2. Production of reactive oxygen and nitrogen species and its neutralization. Superoxide 
anion is produced by the mitochondria, endoplasmic reticulum, NADPH oxidase, cytochrome P450 and 
xanthine oxidase and is scavenged by superoxide dismutase that converts it into hydrogen peroxide. 
Catalase and glutathione peroxidase may breakdown hydrogen peroxide into water. The action of 
antioxidants is necessary because an imbalance between superoxide and hydrogen peroxide leads to the 
formation of hydroxyl ion. In the other side, superoxide can interact with nitric oxide and form a powerful 
pro-oxidant, peroxynitrite. Extracted from Burton and Janiaux 2011. 
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Nitrative stress is also a biological process that alters the placental function. The 
most important RNS are nitric oxide (NO). It has a role, likely a signalling one, in the 
trophoblast invasion and in the maternal-foetal circulation. When NO and O2
- interact 
with each other, they generate a potent pro-oxidant, peroxynitrite that affects placental 
physiology (Webster, Roberts et al. 2008). 
It is believed that local cellular redox imbalance may lead to alterations in 
cellular signalling pathways and also induce damage to biomolecules such as proteins, 
lipids or DNA. These events originate cellular dysfunction and may contribute to the 
development and maintenance of pregnancy-related complications (Myatt and Cui 
2004). 
 
1.3. Oxidative stress biomarkers 
 
1.3.1. Protein carbonylation 
 
Protein carbonylation is an irreversible protein oxidation process promoted by 
ROS (Dalle-Donne, Aldini et al. 2006, Suzuki, Carini et al. 2010), which includes the 
formation of stable carbonyl groups like aldehydes and ketones on protein side chains 
when they are oxidized. The amino acids that are more susceptible to be oxidized in this 
way are proline, arginine, lysine and threonine (Dalle-Donne, Rossi et al. 2003, Dalle-
Donne, Aldini et al. 2006, Wong, Cheema et al. 2008). 
Protein oxidation results in alteration of protein conformation, exposure of 
hydrophobic domain and loss of catalytic function and structural properties (Levine 
2002, Wong, Cheema et al. 2008). This phenomena is often mentioned as a process 
needed in the cells because it may act as a signal mechanism to ensure that defective 
proteins enter the degradation pathway and are degraded by the proteasome (Nystrom 
2005). 
Accumulation of protein carbonyls has been observed in various human age- 
related diseases (Dalle-Donne, Rossi et al. 2003) and during the ageing process (Levine 
2002). Since protein carbonyls are very stable alterations they have been used as 
oxidative stress biomarker. (Dalle-Donne, Aldini et al. 2006, Wong, Cheema et al. 
2008). 
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1.3.2. DNA Damage 
 
DNA damage is described as an alteration in the structure of the DNA caused by 
oxidative stress, UV radiation, alkylating agents or hydrolytic deamination. These 
alterations comprise strand breaks and modifications in purines and pyrimidines 
(Kumari, Rastogi et al. 2008). Free radicals like OH often attack DNA, leading to 
guanine modification and producing of 8-hydroxy-2’-deoxyguanosine (Evans, 
Dizdaroglu et al. 2004, Burton and Jauniaux 2011) that can be measured biochemically 
or detected immunohistochemically (Burton and Jauniaux 2011). This type of 
modification was found increased in placental tissues of pregnancy-associated disorders 
when compared with normal pregnancies (Wiktor, Kankofer et al. 2004). 
 
1.3.3. Lipid Peroxidation 
 
Lipid peroxidation has been defined as the oxidative degradation of lipids that 
contain a number of carbon-carbon double bonds (Devasagayam, Boloor et al. 2003). 
Lipid peroxides are formed when ROS attack the phospholipids presents in cell 
membranes and react with polyunsaturated fatty acids leading to cellular damage 
contribute to the formation of lipid peroxides, lipid hydroperoxides and a secondary 
product of lipid peroxidation, malonaldehyde (Lázár 2012). In fact, it was demonstrated 
that in pregnancy related disorders, an accumulation of lipid peroxides occurs mainly in 
placenta (Agarwal, Gupta et al. 2005). 
 
1.4. Cellular signalling 
 
Environmental signals can regulate cellular activity by binding to cellular 
receptors and activating specific intracellular pathways (Aouadi, Binetruy et al. 2006, 
Berridge 2012). Many of these extracellular signals are transduced by highly conserved 
eukaryotic signalling mechanisms called mitogen-activated protein kinases (MAPKs) 
(Aouadi, Binetruy et al. 2006), members of important signalling pathways that regulate 
physiological processes like cell growth, differentiation and cell death (Junttila, Li et al. 
2008). 
When a stimulus is generated, a phosphorylation cascade is initiated originating 
a protein scaffold where a specific mitogen-activated protein kinase kinase kinase is 
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phosphorylated. It in turn phosphorylates a specific mitogen-activated protein kinase 
kinase that phosphorylates a specific mitogen-activated protein kinase (MAPK) such as 
the extracellular signal-regulated kinase (ERK) 1 and 2, the p38 mitogen-activated 
protein kinase (p38 MAPK) and JNK. In turn, these MAPKs can activate several 
transcription factors and/or cytoplasmatic and nuclear kinases (figure 3) (Aouadi, 
Binetruy et al. 2006, Junttila, Li et al. 2008). 
So far, in mammals, four distinct MAPK signalling pathways were described: 
ERK 1 and ERK 2, that are responsible for cell survival and development, c-jun amino 
terminal kinase or stress-activated protein kinase (JNK/SAPK), p38 MAPK which are 
described as stress activated proteins (SAPK) and play a role in host defence 
mechanisms (Coulthard, White et al. 2009), and ERK5 (Ono and Han 2000, Aouadi, 
Binetruy et al. 2006, Cuenda and Rousseau 2007, Berridge 2012). 
 
 
When a redox imbalance occurs, ROS can induce the activation of MAPK 
signalling pathways. Modification of essential amino acids residues by ROS that 
consequently alters the protein structure and function is one of the plausible 
mechanisms of MAPKs activation (Son, Cheong et al. 2011). In addition, MAPKs 
activation may occur directly by interaction with membrane receptors, such as 
Figure 3. Protein scaffold of MAPK pathways involved in oxidative stress. When an intracellular or an 
extracellular stimulus occurs, the phosphorylation of MAPKKK (MAP3K) is initiated. MAP3K in turn, 
phosphorylates MAPKK (MAP2K), which in succession phosphorylates MAPKs. The activated MAPKs 
consequently phosphorylate several substrates that are important for cellular activities such as development, 
differentiation, growth and apoptosis. Extracted from Son, Cheong et al 2011. 
Introduction 
10 
 
endothelial growth factor receptor and platelet-derived growth factor receptor 
(McCubrey, LaHair et al. 2006) or indirectly due to oxidation of MAPKs related 
proteins, such as protein tyrosine phosphatases (Finkel 2003, Son, Cheong et al. 2011). 
 
1.4.1. Extracellular signal-regulated protein kinase 1 and 2 pathway  
 
ERK 1/2 is a member of one of the most important pathways of MAPK 
signalling (Berridge 2012) once it participates in essential cellular functions as control 
of cell proliferation, differentiation, cell survival and the synaptic plasticity responsible 
for learning and memory (Junttila, Li et al. 2008, Berridge 2012). The ERK 1/2 pathway 
can be activated by mitogens, phorbol esters, growth factors and oxidative stress 
(Daoud, Amyot et al. 2005, Junttila, Li et al. 2008). 
In pregnancy events, ERK 1/2 is also necessary because it is implicated in 
placental development (Aouadi, Binetruy et al. 2006), trophoblast differentiation and 
decidual invasion (Daoud, Amyot et al. 2005, Moon, Park et al. 2008). In fact, it has 
been shown that inhibition of ERK 1/2 alone reduces trophoblast migration (Moon, Park 
et al. 2008) and when in parallel with p38 MAPK decreases trophoblast differentiation 
(Daoud, Amyot et al. 2005). 
 
1.4.2. p38 Mitogen-activated kinase pathway 
 
The p38 MAPK pathway is also an important MAPK signalling pathway 
(Berridge 2012), that is activated by cytokines (Coulthard, White et al. 2009) and a wide 
range of environmental stress agents, as osmotic redox and radiation stress (Berridge 
2012). This pathway is important in the control of apoptosis, inflammation, cell cycle 
regulation, senescence and oncogenesis (Ono and Han 2000, Coulthard, White et al. 
2009). 
The p38 MAPK has four isoforms: p38α, p38β, p38γ and p38δ (Cuenda and 
Rousseau 2007). The p38α isoform is the most well characterized and is described to 
play a vital role in placental embryonic development and placental angiogenesis 
(Mudgett, Ding et al. 2000). In a mouse model, it was demonstrated that disruption of 
p38α results in defective placental angiogenesis, leading to abnormal placental 
development or even to embryo death (Mudgett, Ding et al. 2000). 
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1.4.3. C-jun amino terminal kinase pathway 
 
It is believed that JNK pathway is involved in the control several cellular 
processes such as cellular proliferation, apoptosis and embryonic development 
(Berridge 2012). It was also demonstrated that JNK pathway plays a role on promoting 
cell survival during pre-eclampsia (Padmini, Uthra et al. 2012). 
 
1.5. Pregnancy-associated disorders 
 
1.5.1. Hypertension 
 
Hypertension is the most common disorder during pregnancy. It occurs 
approximately 15 % of pregnancies and may cause maternal and foetal morbidity and 
mortality (James and Nelson-Piercy 2004). 
Hypertension can be divided into 3 groups (James and Nelson-Piercy 2004): 
chronic hypertension, which presently complicates 3% to 5% of pregnancies; 
gestational hypertension complicates 6–7% of pregnancies and resolves post-partum; 
and pre-eclampsia, which complicates 3%-14% of pregnancies (Agarwal, Aponte-
Mellado et al. 2012). Pre-existing hypertension is a risk factor for the development of 
pre-eclampsia. 
 
1.5.1.1. Pre-eclampsia 
 
Pre-eclampsia is known as a complex pregnancy multisystem disorder that 
affects both the mother and foetus (Hubel 1999, Gupta, Agarwal et al. 2005). It has an 
incidence between 3%-14% (Agarwal, Aponte-Mellado et al. 2012) and is the leading 
cause of maternal and foetal morbidity and mortality (Hubel 1999, Agarwal, Aponte-
Mellado et al. 2012). Pre-eclampsia is characterized by hypertension, edema and urinary 
albumin loss (Serdar, Gür et al. 2002), generalized vasospasm (Lázár 2012)  that may 
lead to renal, liver and brain damage in the setting of eclampsia. In addition, it can lead 
to placental abruption, preterm delivery, IUGR and foetal death (Sibai, Dekker et al. 
2005, Steegers, von Dadelszen et al. 2010). In this pregnancy disorder, trophoblast 
invasion is limited into the decidua basalis and insufficient spiral arteries remodelling 
occurs (figure 4) (Hubel 1999, Jauniaux, Poston et al. 2006, Redman and Sargent 2009). 
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Figure 4. Trophoblast invasion and spiral arteries remodelling. Trophoblasts invade the decidua 
basalis and the adjacent myometrium leading to a remodelling of spiral arteries that become flaccid 
vessels. In pregnancy disorders like preeclampsia and IUGR the trophoblasts invade only the decidua 
basalis and the remodeling of spiral arteries is limited to the same tissue. Extracted from Bell 2004.  
 
In a normal pregnancy, trophoblasts invade both decidua basalis and the adjacent 
myometrium leading to a remodelling of the spiral arteries (Lyall 2002). However, in 
the case of pre-eclampsia, trophoblast invasion and spiral arteries remodelling into 
flaccid vessels is restricted to the decidua basalis (Hubel 1999, Roberts and Escudero 
2012). Deficient placentation will alter blood flow and result in an intermittent velocity 
of the utero-placental arterial blood flow with phenomena of hypoxia/reperfusion, 
which in turn leads to enhanced ROS production and OS establishment (Redman and 
Sargent 2009). It is believed that OS is an important factor in the development of this 
pathology (Hubel 1999, Gupta, Agarwal et al. 2005). 
In placentae from pre-eclamptic women it was demonstrated that both the 
expression and activity of total SOD were decreased (Hubel 1999). Phospho-p38α and 
ERK1/2 were also significantly reduced (Webster, Brockman et al. 2006). Protein 
carbonylation, lipid peroxidation and DNA damage were also reported to be higher in 
the placenta and in decidua basalis from pregnancies complicated with preeclampsia 
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when compared with normal pregnancies (Serdar, Gür et al. 2002, Myatt and Cui 2004, 
Fujimaki, Watanabe et al. 2011). 
 
1.5.1.2. Intrauterine Growth Restriction 
 
IUGR is described as a pregnancy complication in which there is a failure of the 
foetus from achieving its genetic growth potential (Scifres and Nelson 2009, Lázár 
2012). It may lead to foetal death, perinatal morbidity and in child it may lead to 
lifelong disorders such as hypertension, renal and cardiovascular diseases (Scifres and 
Nelson 2009). Aneuploidies, malformations, infections, metabolic factors, placental 
disorders and OS are recognized as causes for IUGR (Scifres and Nelson 2009, Lázár 
2012). 
In IUGR, as in pre-eclampsia, a deficient trophoblast invasion and insufficient 
spiral arteries remodelling, confined to the decidua basalis, is also observed (Jauniaux, 
Poston et al. 2006, Redman and Sargent 2009, Scifres and Nelson 2009). This leads to a 
hypoxia/reperfusion phenomena resulting from reduced velocity of the utero-placental 
arterial flow which, once again, leads to local OS (Redman and Sargent 2009) that is 
also thought to antedate the development of this pathology (Hubel 1999, Gupta, 
Agarwal et al. 2005). 
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1.6. Aims 
 
Information about the age-related role of oxidative and nitrative stress in 
signalling mechanisms of placenta and placental bed remain rather vague. It is thus 
important to improve our knowledge on the damage caused by redox imbalance in these 
tissues. Although no single theory purposes an inclusive explanation for the 
mechanisms underlying ageing, a better understanding of the downstream effects of 
imbalanced redox status in cells from the reproductive tract may enhance our 
understanding of female reproductive ageing. In the future, it may lead to the 
development of preventive or therapeutic strategies answering to improve placenta 
function and reduce morbidity and mortality associated to pregnancy in aged women. 
Based on the published knowledge about OS in the placental bed and its 
consequence on pregnancies, it is hypothesized that at older reproductive age, the uterus 
is more prone to redox homeostasis imbalance, which, as consequence, alters key 
signalling pathways at the uterine placental site that contribute to disruption of 
foetal/placental interactions and increases the likelihood of developing pregnancy 
complications. Therefore, to address this hypothesis three major aims were defined: 
1) Determine oxidative stress status in uterine samples from placental bed of young 
and aged pregnant women; 
2) Evaluate, the effect of women’s age in the local modulation of cell signalling; 
3) Determine oxidative stress status in uterine samples from placental bed of young 
and aged pregnant women with chronic hypertension, chronic hypertension and 
pre-eclampsia and gestational hypertension and intrauterine growth restriction of 
the foetus. 
 
  
 
 
 
 
 
Methods 
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2. Methods 
 
2.1. Tissue collection 
 
Dr. Luis Guedes-Martins, MD, PhD Student, from Centro Hospitalar do Porto, 
EPE, collected all human samples. The protocol was approved by ethical committee of 
“Centro Materno-Infantil do Porto”. Volunteers, in accordance with the Institution’s 
guidelines, gave written consent to be included in this study. All human samples were 
collected at delivery by elective caesarean section. Uterine pieces were taken from the 
placental site, processed for structural studies and a stock was stored at – 80 ºC for 
molecular study. 
Women were separated into four groups. Group one had no pathologies; group 
two had gestational hypertension plus IUGR; group three had chronic hypertension; 
group four had chronic hypertension plus pregnancy-associated pre-eclampsia. 
 
2.2. Tissue lysation 
 
A small unthawed portion of tissue was cut from samples frozen at -80 ºC and 
cut again to smaller portions. Tissue was homogenized, using a glass homogenizer 
(Heidolph), in 500 µL of ice-cold lysis buffer (10 mM NaCl, 5 mM EDTA, 50 mM 
Tris-HCl pH 7.5 and 1% SDS) containing proteases inhibitors (P8340, Sigma-Aldrich) 
and phosphatases inhibitors (P0044, P5726, Sigma-Aldrich). Afterwards, the lysates 
were sonicated and centrifuged at 1500 rpm for 5 minutes. The pellet was rejected and 
supernatants were stored at -80 ºC for future experiments. 
 
2.3. Protein quantification – Lowry method 
 
The protein content of tissue lysates was determined by Lowry method using 
Folin-Ciocalteau reagent (F-9252, Sigma-Aldrich) and BSA (A9647-1006, Sigma-
Aldrich) as standard. The albumin standard curve was prepared as shown in table I 
departing from an albumin stock solution of 2 µg/µL. 
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Table I - BSA standard curve. 
Samples Albumin solution (µL) Protein mass (µg) Sample buffer  (µL) 
Blank 0 0 200 
P1 40 0.4 160 
P2 80 0.8 120 
P3 120 1.2 80 
P4 160 1.6 40 
P5 200 2 0 
 
Tissue lysate samples (50 µL) were pre-incubated with the reactive mixture (250 
µL) for 10 minutes, at room temperature, which was prepared by mixing 2.5 µl of 1% 
CuSO4 with 2.5 µl of 2% KNaC4H4O6 followed by the addition of 245 µl of 2% NaCO3 
in 0.1 N NaOH. After pre-incubation Folin-Ciocalteau reagent (25 µl diluted with water 
in the proportion of 1:1) was added to the mixture and in the dark for 30 minutes, at 
room temperature for colour development. The mixture was transferred to a 96 well 
plate (Sarstedt) and protein content was measured by spectrophotometry (Tecan ®), at 
750 nm. 
 
2.4. Western Blotting 
 
Equal amounts of protein were mixed with 4x sample buffer (1,875 M Tris-HCl 
pH 8.8, 8% SDS, 40% glycerol, 0.5 M EDTA, 1 M DTT and 0.2% Bromophenol blue), 
heated at 65 ºC for 15 minutes, then at 95 ºC for 5 minutes and centrifuged at 15 000 for 
5 minutes. The samples were resolved in Laemmli electrophoresis running buffer (125 
mM Tris Base, 250 mM Glycine, 0,1% SDS), in a SDS-Page System set (BioRad) for 1 
hour, at 25 mA/gel unit, and electrotransferred to a nitrocellulose membrane in Tris-
glycine transfer buffer (25 mM Tris Base, 390 mM Glycine and 0.37% SDS) containing 
20% methanol for 2 hours, at 25 volts. Afterwards, membranes were washed in distilled 
water, stained with Ponceau S (0.2% Ponceau, 3% trichloroacetic acid and 3% 
sulfosalicylic acid) and photographed in a Chemidoc
TM
 MP imaging system (BioRad). 
Then, they were washed with TBS-T (20 mM Tris, 137 mM NaCl, 0.05 mM tween ® 
20), blocked for 1 hour in 5% non-fat dry milk in TBS-T and incubated with the 
appropriated primary antibody overnight at 4 ºC, with agitation. In the following day, 
membranes were washed with TBS-T for 30 minutes (TBS-T was changed every 10 
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minutes) and probed with donkey secondary antibody [1/15000 anti-rabbit HRP (711-
035-152, Jackson ImmunoResearch)] in 5% non-fat dry milk in TBS- T for 1 hour at 
room temperature, also with agitation. Blots were then washed with TBS-T for 30 
minutes (TBS-T was changed every 10 minutes) and detected with a chemiluminescent 
agent (170-5061, BioRad) for 5 minutes, at room temperature. The reaction was 
visualized in a Chemidoc
TM
 MP imaging system (BioRad). 
The Ponceau S staining was used for protein normalization and quantification 
was performed using Image version 4.0.1 (BioRad). 
Table II – Primary antibodies used 
Primary antibodies Dilution Reference, Company 
SOD I 1:2000 SOD-100 Stressgen Biotechnologies 
SOD II 1:2000 SOD-110, Stressgen Biotechnologies 
Sirtuin 2 1:1000 S8447, Sigma-Aldrich 
HSP70 1:1000 #4873, Cell Signal 
Phospho-p38α 1:500 #9215, Cell Signal 
Phospho-JNK 1:1000 Sc-6254, Santa Cruz Biotechnologies 
 
2.5. Protein carbonylation 
 
Tissue lysation, protein quantification, electrophoresis, electrotransference and 
Ponceau S staining were performed as described in Western Blotting. Membranes were 
then equilibrated in 20% methanol (32213, Sigma-Aldrich) in TBS for 5 minutes and 
washed in 10% TFA (20751-261, Merck) for 5 minutes. Afterwards, membranes were 
incubated in 10 mM DNPH (42210-256-F, Sigma-Aldrich) in 10% TFA for 10 minutes 
in the dark, at room temperature, with agitation. Membranes were washed first in 10% 
TFA for 25 minutes (TFA was changed every 5 minutes) and then in 50% methanol for 
5 minutes. Next, membranes were blocked in 5% BSA in TBS-T for 1 hour and 
incubated with appropriated rabbit primary antibody (1/10000 anti-DNP) (D9656, 
Sigma-Aldrich) overnight, at 4 ºC. In the next day, membranes were washed with TBS-
T for 30 minutes (TBS-T was changed every 10 minutes) and probed with fluorescent 
secondary antibody (1/15000 goat anti-rabbit; 926-32213, Li-Cor Biosciences) in 5% 
BSA in TBS-T for 1 hour in the dark, at room temperature, with agitation. Blots were 
then washed, in the dark, with TBS-T for 20 minutes, (TBS-T was changed every 10 
minutes) and washed again with TBS-Triton 0.2% (T9284, Sigma-Aldrich) for 10 
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minutes. Membranes were visualized in an Odyssey® CLx Infrared Imaging System 
(Li-Cor Biosciences). 
The Ponceau S staining was used for protein normalization and quantification 
was performed using Image Studio Lite version 3.1 (Li-Cor Biosciences). 
 
2.6. Human Cell Stress Array 
 
The antibody array (ARY018, R&D Systems) is composed of 26 cell stress-
related proteins, listed in table III. All the above-described procedures were performed 
following the manufacturer’s instructions. 
A similar small portion of tissue was cut from samples frozen at -80 ºC (without 
thawing) and crushed in a glass homogenizer (Heidolph) with PBS (10 mM dissodium 
phosphate, 1,8 mM monopotassium phosphate, 137 mM sodium chloride, 2,7 mM 
potassium chloride) containing proteases inhibitors (P8340, Sigma-Aldrich) and 
phosphatases inhibitors (P0044, P5726, Sigma-Aldrich). After homogenization, Triton 
X-100 (T9284, Sigma-Aldrich) was added to a final concentration of 1% and samples 
were frozen at -80 ºC. Tissue lysates were then thawed and centrifuged at 1000 rpm for 
5 minutes. Protein quantification was performed by Bradford method (described below). 
Nitrocellulose membranes containing the antibodies were blocked with array 
buffer 6 for 1 hour, at room temperature, with agitation in an appropriate 4-well multi-
dish plate. While the membranes were blocking, 600 µg of protein (up to 1 ml) was 
mixed with 500 µL of array buffer 4 and then with array buffer 6 to a final volume of 
1.5 ml. Reconstituted Detection Antibody Cocktail (20 µl) was added to the mixture and 
incubated for 1 hour, at room temperature. After aspiration of the array buffer 6 from 
the 4-well multi-dish plate sample/antibody mixtures were added to the nitrocellulose 
membranes and incubated overnight at 4 ºC, with agitation. 
In the following day, membranes were washed with wash buffer for 30 minutes 
(wash buffer was changed every 10 minutes) and incubated with diluted streptavidin-
HRP in array buffer 6 for 30 minutes, at room temperature, with agitation. Membranes 
were then washed for 30 minutes (wash buffer was changed every 10 minutes) and 
incubated with Chemi Reagent Mix for 5 minutes, at room temperature. The reaction 
was visualized in a Chemidoc
TM
 MP imaging system (BioRad). 
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Table III. Capture antibodies in human cell stress array. 
ADAMTS1 HIF-2α Phospho-p38α (T180/Y182) 
Bcl-2 Phospho-HSP27 (S78/S82) Phospho-p53 (S46) 
Carbonic Anhydrase IX HSP60 PON1 
Cited-2 HSP70 PON2 
COX-2 IDO PON3 
Cytochrome c Phospho-JNK Pan (T183/Y185) Thioredoxin 
Dkk-4 NFkB1 Sirtuin2 
FABP1/ L-FABP p21/CIP1 SOD2 
HIF-1α p27/ Kip1  
Table abbreviations: ADAMTS1 - A Disintegrin And Metalloproteinase with Thrombospondin Motifs 1, Bcl-2 - B-cell lymphoma 
2, Cited-2 - Cbp/p300-interacting transactivator 2, COX-2 -  ciclo-oxigenase 2, Dkk-4 - Dickkopf-related protein 4, FABP-1 - Fatty 
acid protein binding 1, HIF - Hypoxia-inducible factor , HSP27 – Heat shock protein 27, HSP60 – Heat shock protein 60, Heat 
shock protein 70, IDO - Indoleamine-pyrrole 2,3-dioxygenase, JNK - c-Jun N-terminal kinases, NFkB1 - Nuclear factor NF-kappa-
B p105 subunit , p21/CIP1 - Cyclin-dependent kinase inhibitor 1A , p27/ Kip1 - Cyclin-dependent kinase inhibitor 1B, PON - 
Serum paraoxonase/arylesterase, SOD2 – Superoxide dismutase 2   
 
2.7. Protein quantification – Bradford method 
 
A commercial Bradford solution 5x (BioRad) was diluted to a bradford solution 
1x, in water. The albumin standard curve was prepared as shown in table IV departing 
from an albumin stock solution of 1 µg/µL. 
Table IV – BSA standard curve. 
Samples Albumin solution (µL) Protein mass (µg) Sample buffer (µL) 
Blank 0 0 100 
P1 20 0.2 80 
P2 40 0.4 60 
P3 60 0,6 40 
P4 80 0,8 20 
P5 100 1 0 
 
In a 96 well plate (Sarstedt) 5 µL of each sample or standards were mixed with 
95 µL of Bradford solution 1x. Mixture was left reacting 5 minutes at room temperature 
and protein content was measured by spectrophotometry (Tecan ®) at 595 nm. 
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2.8. Human Phospho-kinase Array kit 
 
Tissue lysation and protein quantification were performed as described in human 
cell stress array Kit. The human phospho-kinase array kit (Ary 003B, R&D Systems) 
comprises a panel of site-specific phosphorylation of 43 kinases and 2 related total 
proteins listed in table V. All the above-described procedures were employed following 
the manufacturer’s instructions. 
For each sample two nitrocellulose membranes (Part A and Part B) containing 
the antibodies were blocked with array buffer 1 for 1 hour, at room temperature, with 
agitation. While membranes were blocking, 600 µg of protein (up to 334 µL) was mixed 
with array buffer 1 to a final volume of 2 ml. After aspiration of blocking buffer, 1 ml 
of sample mixture was added to part A and B of the nitrocellulose membrane and 
incubated overnight at 4 ºC, with agitation. 
In the following day, membranes were washed for a total time of 30 minutes 
(with buffer changes every 10 minutes) and each membrane A and B were incubated 
with the respective detection antibody cocktail for 2 hours, at room temperature, with 
agitation. Then, membranes were washed again for 30 minutes (wash buffer was 
changed every 10 minutes) and incubated with diluted streptavidin-HRP for 30 minutes, 
at room temperature, with agitation. Finally, membranes were severally washed for 30 
minutes (wash buffer was changed every 10 minutes) and incubated with Chemi 
Reagent Mix for 5 minute, at room temperature. The reaction was visualized in 
Chemidoc
TM
 MP imaging system (BioRad). 
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Table V. Capture antibodies in human phospho-kinase array kit. 
Akt (S473) Hck (Y411) PRAS40 (T246) 
Akt (T308) HSP27 (S78/S82) PyK2 (Y402) 
AMPKα1 (T174) HSP60 RSK1/2/3 (S380/S386/S377) 
AMPKα2 (T172) JNK pan (T183/Y185, T221/Y223) Src (Y419) 
Β-catenin Lck (Y394) STAT2 (Y689) 
Chk-2 (T68) Lyn (Y397) STAT3 (S727) 
c-jun (S63) MSK 1/2 (S376/S360) STAT3 (Y705) 
CREB (S133) P27 (T198) STAT5a (Y694) 
EGF R (Y1086) P38α (T180/Y182) STAT5a/b (Y694/Y699) 
eNOS (S1177) P53 (S1S) STAT5b (Y699) 
ERK 1/2 (T202/Y204, T185/Y187) P53 (S392) STAT6 (Y641) 
FAK (Y397) p 53 (S46) TOR (S2448) 
Fgr (Y412) p70 S6 Kinase (T421/S424) WNK-1 (T60) 
Fyn (Y420) PDGF Rβ (Y751) Yes (Y426) 
GSK-3α/β (S21/S9) PLCγ-1 (Y783)  
Table abbreviations: Akt – Protein kinase B, AMPKα1 - AMP-activated protein kinase alpha 1, AMPKα2 - AMP-activated protein 
kinase alpha 2, Chk-2  - Checkpoint kinase 2, CREB - cAMP response element-binding protein, EGF R - Epidermal growth factor 
receptor, eNOS – Endothelial nitric oxide synthases, ERK1/2 – Extracellular  signal-regulated kinase 1 and 2, FAK - Focal 
Adhesion Kinase, Fgr - Feline Gardner-Rasheed sarcoma viral oncogene,  GSK-3α/β - Glycogen Synthase Kinase 3 alpha and beta, 
Hck - hemopoietic cell kinase, Lck - Lymphocyte-specific protein tyrosine kinase, Lyn - v-yes-1 Yamaguchi sarcoma viral, MSK 
1/2- mitogen- and stress-activated kinase 1 and 2, PDGF Rβ - Platelet-derived growth factor receptor beta, PLCγ-1 - 
Phosphoinositide-specific phospholipase C gama 1, PyK2 - Pyruvate kinase 2, RSK1/2/3 - Ribosomal s6 kinase 1, 2 and 3, Src- v-
src avian sarcoma (Schmidt-Ruppin A-2) viral oncogene, STAT - Signal transducer and activator of transcription, WNK-1 - WNK 
lysine deficient protein kinase 1. 
 
2.9. Statistical analysis 
 
Arithmetic means are given with standard error mean (SEM). Statistical analysis 
was carried out with a Student's t-test. All the association between protein expression 
and increasing maternal age was calculated using the Pearson correlation coefficient (r). 
The respective plots display a fitted linear regression line. A P-value less than 0.05 was 
assumed to denote a significant difference. 
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3. Results 
 
3.1. Reproductive ageing and redox balance in placental bed. 
 
3.1.1. Protein array. 
 
It is known that cellular oxidative stress may alter cell function and contribute to 
the development of several pregnancy-related pathologies. Knowing that age is also a 
risk factor for their development, it was decided to evaluate the expression of several 
cell stress related proteins in tissue lysates from placental bed of young (less than 25 
years-old) and reproductively older (more than 34 years-old) women. The array was 
performed according to manufacturer’s instructions and results are shown in table VI 
and figure 5. 
Table VI enumerates the 16 cell stress-related proteins that are expressed in 
placental bed. 
 
Table VI - Identification of cell stress-related proteins in placental bed tissue. 
Cell stress-related proteins expressed 
ADAMTS1 NFkB1 
Cited-2 P27 
Cytochrome c Phospho-p38α 
FABP-1 PON1 
HSP60 PON2 
HSP70 Thioredoxin-1 
IDO SIRT2 
Phospho-JNK Pan SOD2 
 
For each protein expressed the average signal of protein duplicate spots was 
quantified and a ratio between reproductive older versus young women was determined. 
A ratio superior to 1 indicates increased protein expression in reproductively aged 
women. It was considered that a protein increase over 20% might denote biological 
significance. Cytochrome c, FABP-1, sirtuin 2, SODII, thioredoxin, phospho-p38α and 
ADAMST-1 all had a mean increase in protein expression superior to 20%. However, in 
the human cell stress array statistical significance was only obtained for cytochrome c, 
FABP-1 and ADAMTS1 (figure 5). 
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A B 
 
 
 
Figure 5. Human cell stress array profile in placental bed. Relative expression of 26 cell stress related 
proteins was determined in placental bed lysates from young (less than 25) and reproductively older 
(more than 34) women. (A) Representative arrays. (B) Ratio reproductive older/young of the 
quantification of the average signal of protein duplicates. Columns represent the mean of 3 experiments 
per group; vertical lines show error bars. (*) Significantly different from control values using the student t 
test (P < 0.05). 
 
3.1.2. Western blotting – Protein array validation. 
 
To validate the results obtained in the cell stress-related protein array the effect 
of maternal age in the expression of sirtuin 2, SODII, HSP70 and phospho-p38α was 
evaluated by western blotting. 
In the cell stress-related protein array, sirtuin 2 expression in placental bed had a 
mean increase over 20%. Western blot results for sirtuin 2 denote an increase in protein 
expression in women with advanced reproductive age (Figure 6 A and B). A Pearson 
correlation value of 0.52 suggests a moderate positive correlation, but it did not reach 
statistical significance. Western blot for SODII was also performed and results are 
shown in figure 6 C and D. SODII expression increased significantly along maternal 
age. As for sirtuin 2, a Pearson correlation value of 0.51 suggests a moderate positive 
correlation between SODII expression and maternal age. HSP70 western blot results 
confirm the expression pattern obtained in the cell stress array. No correlation was 
observed between maternal age and HSP 70 expression in placental bed (Figure 6 E and 
F). No correlation was also observed between maternal age and protein expression 
regarding phospho-p38α protein expression (Figure 6 G and H). The great dispersion 
observed in the plotted values confirms the major error bar obtained in the array. 
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The results obtained in western blot studies are consistent with the results from 
the array and thus validate the obtained data. 
 
A C 
  
B D 
  
E G 
  
F H 
  
Figure 6. Effect of age on cell stress-related protein expression. Protein expression was determined in 
placental bed tissue obtained from women between 22 and 41 years old. (A, C, E, G) Representative 
western blots for Sirtuin 2, SODII, HSP70 and phospho- p38, respectively. Quantification of sirtuin 2 (B), 
SODII (D), HSP70 (F) and phospho p38 (H) protein expression. In each experiment the Ponceau S 
staining was used for protein normalization. Data are expressed as relative densitometric units and are 
plotted according to maternal age (r Pearson coefficient). 
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3.1.3. Oxidative stress marker - protein carbonylation. 
 
Oxidative stress may modify biological molecules. In the case of proteins, ROS 
may lead to the oxidation of amino acid residue side chains, to the formation of protein-
protein cross-linkages and to oxidation of protein backbone, which result in loss of 
function and protein fragmentation (Berlett and Stadtman 1997). These oxidative 
modifications lead to the formation of protein carbonyl derivatives, which are 
commonly seen as a biomarker of oxidative stress. Western blotting using an anti-DNP 
antibody was the method used to detect and quantify protein carbonylation in placental 
bed samples. 
 
A B 
 
  
Figure 7. Effect of age on DNP expression. DNP expression was determined in placental bed tissue 
obtained from women between 22 and 41 years old. (A) Representative western blots. (B) Quantification 
of protein expression. In each experiment the Ponceau S staining was used for protein normalization. Data 
are expressed as relative densitometric units and are plotted according to maternal age (r Pearson 
coefficient). 
 
After quantification of total protein carbonylation in the analysed samples, no 
correlation was observed between these two variables. However, when performing 
quantification of protein carbonylation by western blot it is possible to measure specific 
carbonylation bands. As such, proteins highly carbonylated were given random letters 
from A to D and quantified separately. Figure 8 shows that a moderate positive 
correlation, with statistical significance, between age and specific carbonylation of 
protein A is occurring. 
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A B 
  
C D 
  
Figure 8. Effect of age on DNP expression in different proteins . DNP expression was determined in 
placental bed tissue obtained from women between 22 and 41 years. (A, B, C, D) Quantification of 
protein A, protein B, protein C and protein D carbonylation, respectively. In each experiment the Ponceau 
S staining was used for protein normalization. Data are expressed as relative densitometric units and are 
plotted according to maternal age (r Pearson coefficient). 
 
3.2. Reproductive ageing and cell signalling. 
 
3.2.1. Protein array. 
 
As oxidative stress can alter cell signalling and thus affect important cell 
functions it was evaluated a panel of site-specific phosphorylation of 43 kinases using 
the human phospho-kinase array kit (Ary 003). The array was performed according to 
manufacturer’s instructions and results are shown in figure 9 and table VII. 
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Table VII - Identification of phospho-kinase proteins expressed in placental bed tissue. 
Phospho-kinase proteins expressed 
p38 α RSK 1/2/3 PDGF Rβ Lck 
Erk 1/2 eNOS STAT5a/b STAT 2 
JNK Pan Fyn WNK 1 STAT 5a 
GSK-3α/β Yes PYK2 p70 S6 kinase 
P53 Fgr PRAS40 PLC-γ1 
EGF R STAT 6 HSP60 Hck 
MSK1/2 STAT 5b c-Jun Chk-2 
AMPKα1 STAT3 (S727) Src FAK 
Akt STAT3 (Y705) Lyn CREB 
TOR p27 β-catenin HSP27 
AMPKα2    
 
After quantification of the average signal of phosphorylated protein duplicate 
spots, a ratio between reproductive older versus young women was determined. A ratio 
superior to 1 indicates increased protein expression in reproductively aged women. The 
criteria used in the analysis of the present array were the same as for the human cell 
stress array. It was considered that an increase/decrease over 20%, in the specific 
phosphorylation site analysed, might denote biological significance. It was observed 
that the protein with a ratio superior to 1 was phospho-Stat3. Stat 3 had an increase in 
protein phosphorylation of 139% in S727 and 22% in Y705. Proteins with a decrease 
over 20% were JNK pan (T183/Y185, T221/Y223), MSK1/2 (S376/S360), Akt (S473), 
c-jun (S63), p53 (S392), Gsk3-α/β (S21,S9), STAT5b (Y699), LCK (Y394) and Fgr 
(Y412) (figure 9). 
Figure 9. Human phospho-kinase array profile in placental bed. Relative expression of 43 kinase and 
2 related proteins was determined in placental bed lysates from young (less than 25) and reproductively 
older (more than 34) women. (A) Representative arrays. (B) Ratio reproductive older/young of the 
quantification of the average signal of protein duplicates obtained in placental bed tissue lysates. 
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For array confirmation, phospho-JNK was evaluated by western blot. 
 
3.2.2. Western blotting – Protein array validation. 
 
To validate the results obtained in the human phospho-kinase array kit, phospho-
JNK1/2 expression was determined in lysates from placental bed tissue. Figures 10 
represents the relative blots of phospho-JNK1 and phosho-JNK2, respectively. 
After normalization with Ponceau S, no significant changes were observed for 
both phospho-JNK1 and phospho-JNK2. 
 
A C 
  
B D 
  
Figure 10. Effect of age on phospho-kinase protein expression. Protein expression was determined in 
placental bed tissue obtained from women between 22 and 41 years old. (A, C) Representative western 
blots for phospho-JNK 1 and phospho-JNK2, respectively. Quantification of phospho-JNK1 (B), 
phospho-JNK2 (D). In each experiment the Ponceau S staining was used for normalization. Data are 
expressed as relative densitometric units and are plotted according to maternal age (r Pearson coefficient). 
 
3.3. Redox balance in placental bed and pregnancy-associated disorders. 
 
3.3.1. Western blotting – cell stress related proteins. 
 
Previous studies reported differences in placental antioxidant levels in normal 
and pregnancies associated disorders such as hypertension, preeclampsia and IUGR. 
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Results for the expression of SODI, SODII and sirtuin 2 in placental bed of normal 
pregnancies and pregnancies with associated-disorders are depicted in figures 11-13. 
Figure 11 shows the expression of SODI in normal pregnancies and in pregnancies with 
associated disorders. Following normalization with Ponceau S staining no changes were 
observed in SODI, in pregnancies with gestational hypertension plus IUGR. In the 
group of pregnancies complicated with chronic hypertension and chronic hypertension 
plus pre-eclampsia SODI expression is increased (Figure 11). 
 
A C 
  
B D 
  
Figure 11. Effect of pregnancy related disorders on superoxide dismutase I expression. Protein 
expression was determined in placental bed tissue. (A,C) Representative western blots for SOD I in 
gestational HT plus IUGR, in chronic hypertension and chronic hypertension plus preeclampsia, 
respectively. Quantification of SOD I protein expression in gestational HT plus IUGR (B), in chronic 
hypertension and in chronic hypertension plus pre-eclampsia (D). In each experiment Ponceau S staining 
was used for normalization. Data are expressed as relative densitometric units (r Pearson coefficient). 
 
No changes in the expression levels of SODII isoform were observed in 
placental bed from women with the studied pregnancy-associated disorders (Figure 12). 
The expression of sirtuin 2 was also evaluated in pregnancy-related disorders. 
Sirtuin 2 expression is only significantly increased in placental bed from women with 
pregnancy-associated chronic hypertension and pre-eclampsia (Figure 13). 
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A C 
 
 
B D 
  
Figure 12. Effect of pregnancy related disorders on superoxide dismutase II expression. Protein 
expression was determined in placental bed tissue. (A, C) Representative western blots for SOD II in 
gestational HT plus IUGR, in chronic hypertension and chronic hypertension plus preeclampsia, 
respectively. Quantification of SOD II protein expression in gestational HT plus IUGR (B),  in chronic 
hypertension and in chronic hypertension plus pre-eclampsia (D). In each experiment the Ponceau S 
staining was used for protein normalization. Data are expressed as relative densitometric units. 
 
A C 
  
B D 
  
Figure 13. Effect of pregnancy related disorders on Sirtuin 2 expression. Protein expression was 
determined in placental bed tissue. (A,C) Representative western blots for Sirtuin2 in gestational HT plus 
IUGR, in chronic hypertension and chronic hypertension plus preeclampsia, respectively. Quantification 
of Sirtuin2 protein expression in gestational HT plus IUGR (B),  in chronic hypertension and in chronic 
hypertension plus pre-eclampsia (D). In each experiment Ponceau S staining was used for normalization. 
Data are expressed as relative densitometric units. 
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3.3.2. Oxidative stress marker – protein carbonylation. 
 
It is evidenced that protein carbonylation is increased several pathologies. Figure 
14 shows protein carbonylation in placental bed tissues of the studied pregnancy-
associated disorders. Total protein carbonylation did not show any significant changes. 
 
A C 
  
B D 
  
Figure 14. Effect of pregnancy related disorders on DNP expression. Protein 
expression was determined in placental bed tissue. (A,C) Representative western blots for DNP in 
gestational HT plus IUGR, in chronic hypertension and in chronic hypertension plus preeclampsia, 
respectively. Quantification of DNP protein expression in gestational HT plus IUGR (B), in chronic 
hypertension and in chronic hypertension plus pre-eclampsia (D). In each experiment the Ponceau S 
staining was used for protein normalization. Data are expressed as relative densitometric units. 
 
Specific carbonylation of proteins was performed as in 3.1.3 section. Proteins 
highly carbonylated were given random letters taking into consideration that the letters 
were the same for proteins already quantified in 3.1.3 section and between groups. 
Figure 15 shows that a positive correlation in protein F in gestational HT plus IUGR 
occurs with statistical significance. 
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A B 
  
C D 
  
E F 
  
Figure 15. Effect of gestational hypertension with IUGR on DNP expression in different proteins. 
Protein expression was determined in placental bed tissue. Quantification of protein A expression (A), 
protein C expression (B), protein E expression (C), protein F expression (D), protein G expression (E) 
and protein H expression (F) in gestational HT plus IUGR. In each experiment Ponceau S staining was 
used for normalization. Data are expressed as relative densitometric units. 
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No changes were observed in placental bed protein carbonylation levels for 
chronic hypertension and chronic hypertention plus pre-eclampsia. 
 
A B 
  
C D 
  
Figure 16. Effect of chronic hypertension with or without pre-eclampsia on DNP expression in 
different proteins. Protein expression was determined in placental bed. Quantification of protein A 
expression (A), protein C expression (B), protein F expression (C), protein G expression (D) in chronic 
hypertension with or without PE. In each experiment the Ponceau S staining was used for protein 
normalization. Data are expressed as relative densitometric units. 
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4. Discussion 
 
An age-related decline in female fertility is a well known fact in several species 
(Ito, Miyado et al. 2010). It is considered that there are a number of reasons for this 
decline, being the loss of quality of the eggs released by the ovary one of the most well 
studied (Wu, Tang et al. 2007, Yung, Maman et al. 2010). Eventually, when women 
become pregnant, there is also an age-related increase in the risk of developing 
pregnancy-related disorders that may lead several serious complications that include 
abortion, foetal death, preterm delivery, pre-eclampsia, IUGR and abruption placenta. 
Although during the last decades many studies addressed the placenta of these 
pregnancies, currently it is believed that most of these disorders arise from 
abnormalities in the transformation of the uterine placental bed. There is evidence that 
redox process intervenients, including ROS and anti-oxidant enzymes are important 
players in placentation and an imbalance in this system may lead/contribute to the loss 
of placenta function. It was based on these findings that the hypothesis of the present 
work was developed and the major aims of this project were defined.  
A human cell-stress array kit was used to evaluate oxidative stress status in 
placental bed samples from young and reproductively aged women. The use of the cell 
stress array kit Ary 018 from R&D Systems was chosen because it is a sensitive tool 
that enables the simultaneous detection of 26 cell stress-related proteins in a single 
tissue sample and the detection of changes between samples. As one of the limitations 
of the arrays is the number of samples used, it was necessary to validate the results 
obtained using western blotting. Validation was performed with 4 antibodies against 
proteins that had substantially different expression in the array and similar results were 
obtained. Of the proteins studied in the array, cytochrome c, FABP-1 and ADAMTS1 
were significantly increased. The western blot results also demonstrated that there was a 
positive correlation between maternal age and SODII expression. 
Cytochrome c is an electron-transport protein located in the inner membrane of 
the mitochondria (Velayutham, Hemann et al. 2011). About 15% of cytochrome c is 
tightly bound to the membrane, mediates electron transfer and upon interaction with 
cardiolopin may have a peroxidase activity. The remaining cytochrome c is loosely 
attached and besides participating in electron transport mediates superoxide removal 
and prevents OS. Thus, on different contexts cytochrome c can act as a pro or an anti-
oxidant protein (Hüttemann, Pecina et al. 2011, Velayutham, Hemann et al. 2011). 
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Moreover, cytochrome c can also be an apoptotic factor (Hüttemann, Pecina et al. 
2011). Upon apoptotic stimulation it is released from the mitochondria, activates pro-
caspase 9 and may initiate apoptosis. Further studies would be necessary to elucidate 
the meaning of the age-related increase observed in placental site tissue.  
Regarding FABP-1, it is mainly a cytoplasmatic protein, most extensively 
studied in the liver. It promotes cellular uptake and intracellular utilization of fatty 
acids. In vitro studies using human hepatoma cell lines demonstrated that hat FABP-1 
has an anti-oxidant function (Wang, Gong et al. 2005). In the placenta, elevated levels 
of this protein were found in pregnancies complicated by diabetes and IUGR 
(Magnusson, Waterman et al. 2004). Its expression in placental site tissue has not been 
previously described, nor its possible function in this tissue. 
ADAMTS are known as a desintegrin and metalloproteinase with 
thrombospodin motifs that belongs to the metalloproteinase family ADAMS (a 
desintegrin and metalloproteinase) (Kaushal and Sahah 2000) and are often incorporated 
into the extracellular matrix (Shindo, Kurihara et al. 2000). ADAMTS1 appears to have 
a role in fertility, organ morphology and function and normal growth (Shindo, Kurihara 
et al. 2000). Knock out mice for ADAMTS1 had uterine abnormalities (Kaushal and 
Shah 2000, Shindo, Kurihara et al. 2000). As ADAMST1 is a metalloproteinase present 
in the extracellular matrix (ECM), it may influence ECM remodelling and modify cell 
adhesion (Kaushal and Shah 2000). This remodelling is important for many 
differentiative processes such as trophoblast invasion, uterine and mammary changes 
during menstrual cycle and pregnancy (Streuli 1999). Moreover, in vitro studies 
demonstrated that ADAMTS1 has a potent anti-angiogenic function (Hohberg, Knöchel 
et al. 2011). Having in mind that both uterine remodelling and angiogenesis are 
important for a successful pregnancy and increased expression of ADAMTS1 may 
increase the risk for developing pregnancy-related complications. 
Besides these proteins that had a significantly increased expression in 
reproductively aged women, SODII expression also correlated positively with 
reproductive ageing. Although studies performed in other tissues demonstrated that 
SODII expression decreases with age (Matos, Stevenson et al. 2009, Priyanka, Sharma 
et al. 2013) , it is possible that at 35-40 years this increase reflects a compensation 
facing an increased production of ROS. Evaluation of ROS production in placental site 
could validate this hypothesis. It would be also interesting to measure catalase activity, 
since a decrease in catalase activity along maternal age could cause a reduction of the 
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catalase/SODII ratio indicating a reduction of the placental site tissue scavenging 
efficiency along ageing (Carbone, Tatone et al. 2003). 
All together these results point to an age-related alteration of placental bed redox 
balance. 
It is believed that OS can damage biomolecules like proteins, DNA and lipids. 
As proteins are believed to be the main biomolecule of cells and tissues, they are  
potentially the major targets for oxidative damage (Bozaykut, Sozen et al. 2013). 
Moreover, protein carbonylation is an irreversible protein oxidation that leads to the 
formation of stable carbonyl groups on the protein side chain (Dalle-Donne, Aldini et al. 
2006, Suzuki, Carini et al. 2010). For the above-mentioned reasons, placental bed OS 
status during maternal ageing was evaluated by quantification of protein carbonylation. 
No significant correlation was found between total protein carbonylation and maternal 
age. However, the method used (determination of protein carbonyl groups by western 
blot) allowed the quantification of specific carbonylated proteins (Suzuki, Carini et al. 
2010). As such, specific proteins were assigned letters from A to D. Following this 
approach it was demonstrated that carbonylation of protein A was significantly affected 
by maternal ageing. Knowing that proteins especially rich in arginine, proline, lysine 
and threonine are more prone to protein oxidation these results suggest that in 
reproductively aged women there are mild increases in OS that might be affecting, at 
this point, only specific proteins. Although it is believed that the general function of the 
cells is not compromised this does not rule out the possibility that, at some extent, mild 
increases in OS may induce alterations in cell signalling, even in pregnancies without 
complications. 
The human phospho-kinase array performed in placental site samples from 
young and reproductively aged women demonstrated that there was a slight age-related 
decrease in several kinases, but the phosphorylation level of signal transducer and 
activator of transcription (STAT) 3 was increased more than 100%. STATs are a family 
of proteins involved in cell growth, apoptosis, organogenesis, innate and adaptive 
immunity, cancer and cancer metastasis (Horvath 2000) and embryogenesis (Horvath 
2000, Levy and Lee 2002). It is suggested that STAT3 may be directly activated by 
oxidative stress (Carballo, Conde et al. 1999), which could explain the present finding. 
It has been suggested to exist a connection between STAT3 activity and trophoblast 
invasiveness (Poehlmann, Fitzgerald et al. 2006). The meaning of the observed increase 
of STAT3 expression in placental site needs further research. However, the results 
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obtained from the human phospho-kinase array demonstrate that there is an age-related 
alteration in cell signalling, in placental site tissues obtained from healthy women who 
had pregnancies without complications. 
 
Oxidative stress has been suggested to play an important role in the 
pathophysiology of several pregnancy-related complications (Many, Hubel et al. 2000, 
Scifres and Nelson 2009) as well as in cardiovascular diseases (Elahi, Kong et al. 2009), 
cancer (Sosa, Moliné et al. 2013) and in neurodegenerative diseases (Reynolds, Laurie 
et al. 2007). As such, in the second part of this work it was evaluated the expression of 
two main anti-oxidant enzymes (SOD I and SOD II) and sirtuin 2 (attending to the fact 
that it showed a moderate positive correlation with increased reproductive age) in 
women with pregnancy-related disorders. Two groups of study were defined. Group one 
with women who had gestational hypertension and IUGR of the foetus and group two 
with women that have chronic hypertension with or without pre-eclampsia. SOD I is an 
antioxidant enzyme located in the cytosol while SOD II is located in the mitochondria. 
Both these antioxidant enzymes scavenge superoxide anion into hydrogen peroxide and 
have an important role in the regulation of redox-balance (Burton and Jauniaux 2011). 
Sirtuin 2 is a protein mainly located in the cytoplasm. Sirtuin 2 deacetylates α-tubulin 
and has been implicated in cytoskeleton regulation and progression of cell mitosis 
(Wang, Nguyen et al. 2007, Dan, Klimenkova et al. 2012, Machado de Oliveira, 
Sarkander et al. 2012). 
No significant changes were observed in both SODI and sirtuin 2 expressions in 
women with gestational hypertension and IUGR of the foetus while these enzymes were 
increased in women with chronic HT and chronic hypertension and PE. In the case of 
SODII no changes were observed in placental bed of all the pregnancy disorders 
studied. After western blot analysis it was demonstrated that, although as mentioned in 
the introduction both in IUGR and in PE a shallow trophoblast invasion of placental bed 
occurs, the cellular mechanisms altered in placental bed of these pathologies differ. 
Favouring this statement are the results obtained by the evaluation of protein carbonyl 
contents in the same groups. Protein assigned with the letter F is significantly increased 
only in pregnancies complicated by gestational hypertension and IUGR of the foetus. 
The fact that no significant changes were observed in protein carbonylation in 
pregnancies complicated by PE and only one of the 6 proteins analysed in gestational 
HT and IUGR of the foetus is significantly increased are in agreement with recent 
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findings, that have been well reviewed pointing to an important role of protein nitration 
in the development of pregnancy-related pathologies (Webster, Roberts et al. 2008, 
White, Capobianco et al. 2010). 
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5. Conclusions and future perspectives 
 
This work focused in the evaluation of local redox balance and altered cell 
signalling in placental bed tissues from young and reproductively older women. 
Additionally, redox imbalance in placental bed of pregnancies with associated 
pathologies was also addressed. 
The results of the present thesis indicate an age- and pathology-related redox 
imbalance in placental bed that is accompanied by alterations in cell signalling. 
Furthermore, specific protein modifications, expression and carbonylation, were found 
altered in placental bed. This observation further supports the hypothesis that local 
uterine redox imbalance contributes to the development of placental bed dysfunction. 
Future studies should focus on elucidating the role of these altered proteins in the 
regulation of uterine tissue remodelling. 
The present thesis also emphasises that redox status varies among distinct 
pregnancy-associated disorders. This supports the need to develop specific antioxidants, 
since it is believed that prevention of severe cellular OS during pregnancy can avoid the 
development of pregnancy-associated complications and currently there are no such 
specific molecules available. 
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6. Final remarks  
 
 
1) Part of this work was presented in the following meetings: 
 
Summary in an international congress 
 Soares A, Silveira S, Almeida H, Silva E. “Anti-oxidant supplementation and 
reproductive outcome in aged female mice”. Livro de resumos do 7th Young 
European Scientist Meeting (YES Meeting). 2012: 91. 
 
Communication in an international congress 
 Soares A, Silveira S, Almeida H, Silva E. “Anti-oxidant supplementation and 
reproductive outcome in aged female mice”. 7th Young European Scientist 
Meeting (YES Meeting). Porto. 2012.  
 
Summary in a national meeting 
 Soares A, Silveira S, Almeida H, Silva E. “Aged female diet anti-oxidant 
supplementation improves reproductive outcome”. 3rd I3S Scienticic Retreat. 
Póvoa de Varzim. 2012. 
 
2) Part of this work was funded by “Prémio Crioestaminal 2011” (Federação da 
Sociedade Portuguesa da Ginecologia e Obstetrícia), awarded to Henrique 
Almeida, Luis Guedes-Martins, Elisabete Silva and Liliana Matos. 
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